Rs 124 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Voglimac MF 0.2 mg Tablets offer a dual-action approach to managing both vestibular disorders and diabetes. Each tablet contains 0.2 mg of Betahistine dihydrochloride and 500 mg of Metformin hydrochloride. Betahistine is effective in treating symptoms such as dizziness, vertigo, and tinnitus by improving blood flow to the inner ear, thus stabilizing inner ear pressure and function. Metformin, on the other hand, is a well-established medication for controlling blood glucose levels, making this combination particularly beneficial for patients with diabetes who also suffer from vestibular symptoms. The tablets are designed for ease of use, featuring a convenient form that ensures accurate dosing. Packaged in a 10-tablet bottle, Voglimac MF is suitable for managing both conditions simultaneously, improving overall quality of life by addressing multiple health concerns with a single medication.
Active Ingredients: Each tablet contains 0.2 mg of Betahistine dihydrochloride and 500 mg of Metformin hydrochloride. Dual Therapeutic Action: Combines Betahistine to manage vestibular disorders with Metformin to control blood sugar levels in diabetic patients. Vestibular Disorder Relief: Betahistine helps alleviate symptoms such as dizziness, vertigo, and tinnitus associated with inner ear conditions. Diabetes Management: Metformin helps in managing blood glucose levels, particularly useful for patients with diabetes who also experience vestibular symptoms. Convenient Tablet Form: Available in an easy-to-swallow tablet format, ensuring precise dosing and ease of administration.
VOGLIMAC MF 0.2MG helps regulate blood sugar levels through a combination of actions: Metformin lowers the amount of glucose released into the bloodstream by the liver, while Voglibose reversibly inhibits various carbohydrate-digesting enzymes (such as sucrose, maltase, and zomaltase) in the gut. This results in delayed digestion and absorption of glucose into the bloodstream.
Take VOGLIMAC MF 0.2MG TABLET as prescribed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
PREGNANCY CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is not recommended for use during pregnancy. Consult your doctor before taking it. BREASTFEEDING CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is not recommended for breastfeeding women. Consult your doctor before use. DRIVING AND USING MACHINES USE WITH CAUTION: VOGLIMAC MF 0.2MG TABLET does not directly affect your ability to drive or operate machinery, but it may cause hypoglycemia (low blood sugar). Be aware of symptoms of hypoglycemia, such as weakness, dizziness, rapid heartbeat, vision problems, or difficulty concentrating. Avoid driving or using machinery if you experience these symptoms. ALCOHOL CONSULT YOUR DOCTOR: Avoid consuming alcohol while taking VOGLIMAC MF 0.2MG TABLET, as it may increase the risk of lactic acidosis, dizziness, or drowsiness. Consult your doctor for advice. KIDNEY CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is not recommended for patients with severe kidney disease. Consult your doctor before use. LIVER CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is not recommended for individuals with liver problems. Consult your doctor before use. ALLERGY CONTRAINDICATED: Do not take VOGLIMAC MF 0.2MG TABLET if you are allergic to Metformin or Voglibose. HEART DISEASE CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is not recommended for patients with heart conditions, such as recent heart attack, heart failure, cardiogenic shock, or abnormal breathing. Consult your doctor before use. USE IN PEDIATRICS CONTRAINDICATED: VOGLIMAC MF 0.2MG TABLET is generally not recommended for children and adolescents under 18 due to insufficient safety and effectiveness data. Consult your doctor before use. USE IN GERIATRICS USE WITH CAUTION: VOGLIMAC MF 0.2MG TABLET should be used with caution in elderly patients (65 years or older). Treatment may start with a lower dose based on kidney, liver, or heart function, and your doctor may monitor kidney function more frequently. Consult your doctor before use.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s